Publicacións nas que colabora con Santos Castañeda Sanz (12)

2023

  1. Analysis of the interstitial lung disease pathogenesis in PSGL-1 KO and P-Selectin KOmice

    44 Congreso de las Sociedad Española de Inmunología

  2. Diagnostic predictive value of soluble PSGL-1 and its ligands in patients with Systemicsclerosis (SSc)

    44 Congreso de las Sociedad Española de Inmunología

  3. Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?

    International Journal of Molecular Sciences, Vol. 24, Núm. 17

  4. P-selectin/PSGL-1 axis regulation of autophagy in monocytes from healthy donors andlupus patients

    44 Congreso de las Sociedad Española de Inmunología

  5. PSGL-1/P-selectin interaction reduces the amount of DNA released in monocytesextracelular traps: lack of regulation in SLE patients

    44 Congreso de las Sociedad Española de Inmunología

2022

  1. Characterization of interstitial lung disease present in PSelectin KO mice (Lupus-likesyndrome) and PSGL-1 KO mice (Scleroderma-like syndrome)

    43 Congreso de las Sociedad Española de Inmunología

  2. Targeted nanotherapy with everolimus reduces inflammation and fibrosis in scleroderma-related interstitial lung disease developed by PSGL-1 deficient mice

    British Journal of Pharmacology, Vol. 179, Núm. 18, pp. 4534-4548

2021

  1. Author Correction: BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis (Scientific Reports, (2021), 11, 1, (11510), 10.1038/s41598-021-91055-z)

    Scientific Reports

  2. BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis

    Scientific Reports, Vol. 11, Núm. 1

  3. Role of the IL33 and IL1RL1 pathway in the pathogenesis of Immunoglobulin A vasculitis

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Spontaneous Pulmonary Hypertension Associated With Systemic Sclerosis in P-Selectin Glycoprotein Ligand 1–Deficient Mice

    Arthritis and Rheumatology, Vol. 72, Núm. 3, pp. 477-487

2014

  1. Influence of the IL17A locus in giant cell arteritis susceptibility

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 9, pp. 1742-1745